There’s Still Time to Buy Recursion Pharmaceuticals Inc (NASDAQ:RXRX) Stock
In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $6.62, up 7.12% from the previous session. RXRX stock price is now -0.95% away from the 50-day moving average and -25.40% away from the 200-day moving average. The market capitalization of the company currently stands at $1.93B. With the price target of $8, […]
Recursion Pharmaceuticals Inc (RXRX) – it’s time to buy. Check out key Indicators
In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $6.15, down -4.50% from the previous session. RXRX stock price is now -8.73% away from the 50-day moving average and -31.02% away from the 200-day moving average. The market capitalization of the company currently stands at $1.77B. With the price target of $8, […]
Reasons why Recursion Pharmaceuticals Inc’s (NASDAQ:RXRX) fundamentals are futile
In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $6.11, down -0.97% from the previous session. RXRX stock price is now -12.41% away from the 50-day moving average and -32.26% away from the 200-day moving average. The market capitalization of the company currently stands at $1.76B. With the price target of $8, […]
